| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 1,455.88 | 1,364.01 | 1,502.20 | 1,354.96 |
| Other Net | 1.00 | 3.00 | -2.71 | 10.85 |
| Diluted Weighted Average Shares | 25.63 | 24.86 | 24.85 | 24.82 |
| Gain( Loss)on Saleof Assets | 6.02 | 5.54 | 2.04 | - |
| Depreciation/ Amortization | 66.45 | 61.54 | 55.69 | 51.54 |
| Operating Income | 95.49 | 5.72 | -81.29 | 57.86 |
| Net Income | 21.88 | -35.87 | -121.16 | 40.96 |
| Income Availableto Com Excl Extra Ord | 21.88 | -35.87 | -121.16 | 40.96 |
| Other Operating Expenses Total | 33.15 | 29.32 | 26.07 | 279.05 |
| Net Income Before Taxes | 44.31 | -54.65 | -137.66 | 52.93 |
| Minority Interest | -10.38 | -6.26 | 0.82 | -3.81 |
| Net Income After Taxes | 32.26 | -29.61 | -121.98 | 44.76 |
| Income Availableto Com Incl Extra Ord | 21.88 | -35.87 | -121.16 | 40.96 |
| Costof Revenue Total | 853.84 | 811.86 | 906.09 | 793.00 |
| Gross Profit | 697.54 | 557.87 | 514.82 | 619.82 |
| Interest Inc( Exp) Net- Non- Op Total | -58.20 | -68.90 | -55.70 | -15.77 |
| Unusual Expense( Income) | 5.25 | 17.56 | 65.94 | 0.00 |
| Diluted Net Income | 21.88 | -35.87 | -121.16 | 40.96 |
| Provisionfor Income Taxes | 12.05 | -25.03 | -15.68 | 8.17 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 21.88 | -35.87 | -121.16 | 40.96 |
| Total Revenue | 1,551.37 | 1,369.73 | 1,420.91 | 1,412.82 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 1,551.37 | 1,369.73 | 1,420.91 | 1,412.82 |
| Selling/ General/ Admin Expenses Total | 497.19 | 443.74 | 448.40 | 231.37 |
| Diluted Normalized EPS | 0.83 | -1.13 | -3.20 | 1.65 |
| Diluted EPS Excluding Extra Ord Items | 0.85 | -1.44 | -4.88 | 1.65 |
| DPS- Common Stock Primary Issue | - | - | - | 0.00 |
SeQuent Scientific Dividend SeQuent Scientific Bonus SeQuent Scientific News SeQuent Scientific AGM SeQuent Scientific Rights SeQuent Scientific Splits SeQuent Scientific Board Meetings SeQuent Scientific Key Metrics SeQuent Scientific Shareholdings SeQuent Scientific Balance Sheet SeQuent Scientific Cashflow SeQuent Scientific Q1 Results SeQuent Scientific Q2 Results SeQuent Scientific Q3 Results SeQuent Scientific Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks